May 10th, 2022
NRX Pharma Private Lunch Reception
Speakers:
Robert Besthof, M.I.M., Interim CEO, Randy Guggenheimer, Chief Business Officer, Jonathan Javitt, M.D., M.P.H., Founder & Chief Scientific Officer, NRx Pharmaceuticals, Inc.
- 12:00-13:30
- Hall D
- Kindly RSVP
Teva Pharmaceutical Industries Afternoon Workshop
- 15:00-17:30
- Hall D
May 11th, 2022
Latham & Watkins LLP Private Breakfast Workshop
Topic: US & EU Life Sciences Regulatory Developments Workshop – US FDA, US Healthcare Reimbursement and EU Regulatory
Speakers:
Stuart Kurlander, Partner, Ben Haas, Partner Eveline Van Keymeulen, Partner, Josh Kiernan, Partner, Michael Rosenberg, Counsel, Latham & Watkins
- 09:30-11:30
- Gallery Room
- Kindly RSVP
Hogan Lovells Private Lunch Reception
Topic: 2022 Regulatory Outlook: Medical technology and digital health trends emerging from the pandemic
Speakers:
Michael S. Heyl, Michael (Moshe) Kasser, Stuart M. Langbein, Kelliann H. Payne, Fabien Roy, Jodi Scott
- 12:00-13:30
- Hall D
- Kindly RSVP
Medison and Biogen Private Workshop:
leading a summit on Biopharma / Digital Health collaboration
Topic: Crossing the Chasm: Achieving a Successful Partnership with Biopharma in Digital Health
Speakers:
Steff Bristol, Head of External Innovation & Alliances for AI/ML, and Imaging, Biogen Digital Health, Dr. Nadav Shimoni, Head of Digital health sector, Arkin Holdings, Dr. Matan Soll – Digital analyst, Medison Ventures, Orel Hashmatia – Co-founder & CEO, Causalis.ai, Talor Sax – CEO and partner, eHealth Ventures
- 14:30-16:00
- Hall D
- Kindly RSVP
Greenberg Traurig Private Seminar on current trends in the public and private Capital Markets and M&A arena as well as ways to navigate the current SPAC environment
Topic: Raising Capital, M&A, SPACs and other Exits in the United States
Speakers:
Alan Annex, Co-Chair of Greenberg Traurig’s Global Corporate Practice, Nissim Darvish, Managing Partner of MeOhr Ventures, Bob Grossman, Chair of Greenberg Traurig’s Israel Practice and Corporate Shareholder, Andy Kaye, President and CIO of OurCrowd, Gil Bar-Nahum, Managing Director and EMEA Head of Biotechnology in the Global Healthcare Investment Banking Group of Jefferies
- 17:00-19:00
- Hall D
- Kindly RSVP
